SCI Pharmtech, Inc. (TPE:4119)
Taiwan · Delayed Price · Currency is TWD 52.00
-1.10 (-2.07%)
At close: Feb 11, 2026
SCI Pharmtech Market Cap
SCI Pharmtech has a market cap or net worth of 6.21 billion as of February 20, 2026. Its market cap has decreased by -38.10% in one year.
Market Cap
6.21B
Enterprise Value
7.09B
Revenue
1.39B
Ranking
n/a
PE Ratio
54.09
Stock Price
52.00
Market Cap Chart
Since January 5, 2004, SCI Pharmtech's market cap has increased from 1.06B to 6.21B, an increase of 483.65%. That is a compound annual growth rate of 8.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 6.21B | 6.78% |
| Dec 31, 2025 | 5.82B | -46.25% |
| Dec 31, 2024 | 10.83B | -6.40% |
| Dec 29, 2023 | 11.57B | 24.39% |
| Dec 30, 2022 | 9.30B | 16.07% |
| Dec 30, 2021 | 8.01B | 20.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 13.33B |
| Handa Pharmaceuticals | 11.80B |
| Standard Chemical & Pharmaceutical | 10.85B |
| Formosa Laboratories | 6.82B |
| Orient Pharma | 6.49B |
| Easywell Biomedicals | 4.08B |
| Orient EuroPharma | 3.83B |
| Merdury Biopharmaceutical | 3.58B |